Coronavirus company news summary – Neura launches Covid-19 predictive testing solution – VentilatorSOS ships modified sleep apnea devices to Ecuador, Haiti and Malawi

7 August 2020 (Last Updated August 7th, 2020 09:35)

Biocept and Aegea Biotechnologies have entered into an agreement to co-develop a highly sensitive PCR-based assay, designed by Aegea, to detect the Covid-19 virus. The assay will be based on the Switch-Blocker technology used in Biocept's oncology-focused assays. The test is expected to boost the sensitivity to detect Covid-19-causing SARS-CoV-2 virus and to offer additional information on specific types of strains.

Neura has adopted the ViruScore Covid-19 predictive testing solution. The Human Behavioral Intelligence Platform is said to be the first artificial intelligence-based approach that is used in the field, with HY Laboratories being the main provider of Covid-19 tests solutions in Israel, and using it to grade testing samples to enable efficient test pooling.

Mopec is providing ready-to-ship personal protective equipment (PPE) in response to the ongoing global Covid-19 pandemic. The PPE includes products that are FDA- and CE-compliant, which includes face shields, three-ply and KN95 masks, infrared thermometers, and hand sanitisers. The company’s PPE offerings are a part of its Guardian Systems line of Covid-19 preparation and response products.

VentilatorSOS has shipped sleep apnea devices to the hot spots of the pandemic to aid in the fight against Covid-19. The organisation developed the design to modify unused sleep apnea devices to address the need for ventilators. These shipments are expected to aid patients with Covid-19 in Ecuador, Haiti and Malawi. The VentilatorSOS is searching for a partner to meet the increasing needs around the globe with the millions of unused sleep apnea machines in the US which can be modified.